Healthpeak Properties, Inc. (NYSE:PEAK) Expected to Post Quarterly Sales of $499.99 Million

Wall Street brokerages predict that Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) will post sales of $499.99 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Healthpeak Properties’ earnings, with the highest sales estimate coming in at $519.50 million and the lowest estimate coming in at $486.33 million. Healthpeak Properties posted sales of $476.24 million during the same quarter last year, which would suggest a positive year over year growth rate of 5%. The business is scheduled to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Healthpeak Properties will report full year sales of $2.00 billion for the current financial year, with estimates ranging from $1.92 billion to $2.10 billion. For the next fiscal year, analysts expect that the business will report sales of $2.11 billion, with estimates ranging from $1.97 billion to $2.29 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Healthpeak Properties.

Healthpeak Properties (NYSE:PEAK – Get Rating) last posted its quarterly earnings data on Tuesday, May 3rd. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.29). Healthpeak Properties had a net margin of 22.11% and a return on equity of 4.22%. The firm had revenue of $498.40 million during the quarter, compared to analysts’ expectations of $490.02 million. During the same period in the previous year, the company earned $0.40 earnings per share. The business’s quarterly revenue was up 9.5% on a year-over-year basis.

PEAK has been the subject of several research analyst reports. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $35.50 to $34.50 and set an “equal weight” rating for the company in a research report on Monday, March 7th. Credit Suisse Group lifted their target price on Healthpeak Properties from $37.00 to $38.00 and gave the stock a “neutral” rating in a research report on Monday, April 4th. Finally, Bank of America cut Healthpeak Properties from a “buy” rating to a “neutral” rating and set a $32.00 price objective on the stock. in a research note on Thursday, May 19th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $36.39.

Several large investors have recently added to or reduced their stakes in the stock. Eaton Vance Management lifted its position in shares of Healthpeak Properties by 6,049.9% in the third quarter. Eaton Vance Management now owns 614,256 shares of the company’s stock worth $20,597,000 after purchasing an additional 604,268 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Healthpeak Properties by 6.4% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 87,762 shares of the company’s stock valued at $3,167,000 after purchasing an additional 5,313 shares during the last quarter. Capitolis Advisors LLC increased its position in Healthpeak Properties by 48.5% in the 3rd quarter. Capitolis Advisors LLC now owns 356,283 shares of the company’s stock worth $12,331,000 after purchasing an additional 116,283 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $5,340,000. Finally, Lazard Asset Management LLC lifted its holdings in shares of Healthpeak Properties by 63.8% during the 4th quarter. Lazard Asset Management LLC now owns 3,565 shares of the company’s stock valued at $128,000 after buying an additional 1,389 shares during the last quarter. Institutional investors and hedge funds own 95.98% of the company’s stock.

PEAK stock opened at $29.50 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 0.91. The firm has a 50 day simple moving average of $33.06 and a 200-day simple moving average of $33.67. The company has a market capitalization of $15.92 billion, a P/E ratio of 37.34, a PEG ratio of 2.93 and a beta of 0.73. Healthpeak Properties has a twelve month low of $28.65 and a twelve month high of $37.69.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 20th. Stockholders of record on Monday, May 9th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 6th. This represents a $1.20 annualized dividend and a dividend yield of 4.07%. Healthpeak Properties’s dividend payout ratio is currently 151.90%.

About Healthpeak Properties (Get Rating)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.

Read More